MyFinsight
Home
Blog
About
Contact
chrs: the balance sheet
Download
Download image
Other prepaids and
current assets
$8,700K
Prepaid manufacturing
$8,048K
Inventory
$2,048K
Tsa receivables,
net
$241,251K
Trade receivables,
net
$9,245K
Investments in marketable
securities
$88,311K
Cash and cash
equivalents
$103,352K
Other assets,
non-current
$4,447K
Intangible assets, net
$49,484K
Property and equipment,
net
$1,633K
Total current assets
$460,955K
Total assets
$516,519K
Total liabilities and
stockholders' equity...
$516,519K
Total stockholders'
equity (deficit)
$87,774K
Total liabilities
$428,745K
Accumulated deficit
-$1,345,326K
Accumulated other
comprehensive loss
-$203K
Additional paid-in capital
$1,433,291K
Other liabilities,
non-current
$17,545K
Lease liabilities,
non-current
$1,946K
Term loan,
non-current
$36,957K
Total current
liabilities
$372,297K
Common stock (0.0001
par value shares...
$12K
Accrued and other
current liabilities
$13,101K
Accrued compensation
$13,385K
Tsa payables and
accrued liabilities
$253,908K
Accrued rebates, fees
and reserves
$67,010K
Accounts payable
$24,893K
Back
Back
Balance Sheet
source: myfinsight.com
Coherus Oncology, Inc. (CHRS)
Coherus Oncology, Inc. (CHRS)